Evidence map›Paper›PMID 29861153›Full record

ArticleJournal of chromatography. B, Analytical technologies in the biomedical and life sciences2018

Corrigendum to "Quantitative UPLC-MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency" [J. Chromatogr. B 1036-1037 (2016) 170-177].

Margret Thorsteinsdottir, Unnur A Thorsteinsdottir, Finnur F Eiriksson, Hrafnhildur L Runolfsdottir, Inger M Sch Agustsdottir, Steinunn Oddsdottir, Baldur B Sigurdsson, Hordur K Hardarson, Nilesh R Kamble, Snorri Th Sigurdsson and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Margret ThorsteinsdottirUniversity of Iceland, Reykjavik, Iceland; ArcticMass, Reykjavik, Iceland. Electronic address: margreth@hi.is.
Unnur A ThorsteinsdottirUniversity of Iceland, Reykjavik, Iceland; ArcticMass, Reykjavik, Iceland.
Finnur F EirikssonUniversity of Iceland, Reykjavik, Iceland; ArcticMass, Reykjavik, Iceland.
Hrafnhildur L RunolfsdottirUniversity of Iceland, Reykjavik, Iceland.
Inger M Sch AgustsdottirChildren's Medical Center, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
Steinunn OddsdottirDepartment of Clinical Biochemistry, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
Baldur B SigurdssonArcticMass, Reykjavik, Iceland; Center for Biomedicine, European Academy of Bolzano/Bozen, Bolzano, Italy.
Hordur K HardarsonUniversity of Iceland, Reykjavik, Iceland.
Nilesh R KambleUniversity of Iceland, Reykjavik, Iceland.
Snorri Th SigurdssonUniversity of Iceland, Reykjavik, Iceland.
Vidar O EdvardssonUniversity of Iceland, Reykjavik, Iceland; Children's Medical Center, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
Runolfur PalssonUniversity of Iceland, Reykjavik, Iceland; Division of Nephrology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.

Funding

Primary HyperoxaluriaU54DK083908 · NIDDK · MAYO CLINIC ROCHESTER · PI MILLINER, DAWN SCHMAUTZ · 2009 to 2018
$12.3M
NIDDK NIH HHS U54 DK083908
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29861153
PMCPMC6390279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.